National Institutes of Health: all 11,571 studies

Page 11 of 116. Open to participants first (946), then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate the Effects of Cenicriviroc Mesylate on Arterial Inflammation in People Living With HIVCompletedNCT05630885Phase 2Results posted
• Pharmacokinetics and Safety of Double-dose Dolutegravir When Used With Rifapentine for HIV-associated TuberculosisCompletedNCT05630872Phase 2Results posted
• A Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRCHIVMAB0115-00-AB (VRC01.23LS), Administered Intravenously or Subcutaneously to Healthy AdultsCompletedNCT05627258Phase 1Results posted
• Safety of Intravenous Apramycin in AdultsCompletedNCT05590728Phase 1Results posted
• Siplizumab in T1DMTerminatedNCT05574335Phase 1/2Results posted
• [18F]SF12051 for Imaging the 18-kDa Translocator Protein (TSPO) in Brain and Whole Body of Healthy SubjectsTerminatedNCT05564429Phase 1Results posted
• Tecovirimat for Treatment of Monkeypox VirusCompletedNCT05559099Phase 2Results posted
• Testing the Use of Fulvestrant and Binimetinib Targeted Treatment for NF1 Mutation in Hormone Receptor-Positive Metastatic Breast Cancer (A ComboMATCH Treatment Trial)TerminatedNCT05554354Phase 2Results posted
• Study of Tecovirimat for Human Mpox VirusTerminatedNCT05534984Phase 3Results posted
• [11C]-(R)-Rolipram to Measure cAMP Signaling Before and After KetamineTerminatedNCT05522673Phase 1Results posted
• COVID Protection After Transplant - Sanofi GSK (CPAT-SG) StudyCompletedNCT05518487Phase 2Results posted
• Trial to Evaluate the Immunogenicity of Dose Reduction Strategies of the MVA-BN Monkeypox VaccineCompletedNCT05512949Phase 2Results posted
• Burosumab for Fibroblast Growth Factor-23 Mediated Hypophosphatemia in Fibrous DysplasiaCompletedNCT05509595Phase 2Results posted
• Using Fostamatinib to Treat Post-Hematopoietic Stem Cell Transplant Immune-mediated CytopeniasTerminatedNCT05502783Phase 2Results posted
• Safety and Immunogenicity of CJCV2 With and Without ALFQCompletedNCT05500417Phase 1Results posted
• Testing Copanlisib as a Potential Targeted Treatment in Cancers With PIK3CA Mutations (MATCH-Subprotocol Z1F)Active, not recruitingNCT05490771Phase 2Results posted
• A Clinical Trial to Evaluate Safety, Tolerability, and Immunogenicity of Adjuvanted HIV-1 Fusion Peptide Conjugate Vaccine Alone or in Prime-Boost Regimens With Adjuvanted HIV-1 Envelope Trimer 4571 and HIV-1 Trimer 6931 Vaccines in Healthy AdultsTerminatedNCT05470400Phase 1Results posted
• Neonatal Phase 1 Valacyclovir StudyCompletedNCT05468619Phase 1Results posted
• A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas AeruginosaCompletedNCT05453578Phase 1/2Results posted
• Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin AnalysisCompletedNCT05436535Phase 4Results posted
• Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma After Chemotherapy Has Stopped WorkingActive, not recruitingNCT05432791Phase 2/3Results posted
• Abemaciclib Neuropharmacokinetics of Diffuse Midline Glioma Using Intratumoral MicrodialysisActive, not recruitingNCT05413304Phase 1Results posted
• A Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1CompletedNCT05406583Phase 1Results posted
• Anti-malaria MAb in Kenyan ChildrenCompletedNCT05400655Phase 2Results posted
• Dose Escalation, Open-Label Clinical Trial to Evaluate Safety, Tolerability and Immunogenicity of a Nipah Virus (NiV) mRNA Vaccine, mRNA-1215, in Healthy AdultsCompletedNCT05398796Phase 1Results posted
• Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid MalignanciesCompletedNCT05371054Phase 1/2Results posted
• Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic LupusTerminatedNCT05306873Phase 2Results posted
• CD40L Antagonism in Rheumatoid Arthritis (RA)TerminatedNCT05306353Phase 2Results posted
• Anti-malaria MAb in Malian ChildrenCompletedNCT05304611Phase 2Results posted
• Safety, Tolerability, and Immunogenicity Study of Sm-p80 + GLA-SE (SchistoShield(R)) Vaccine in Healthy AdultsCompletedNCT05292391Phase 1Results posted
• Effect of Ultra-processed Versus Unprocessed Diets on Energy MetabolismCompletedNCT05290064Not applicableResults posted
• COVID-19 Variant Immunologic Landscape Trial (COVAIL Trial)CompletedNCT05289037Phase 2Results posted
• Olaparib in Subjects With Advanced Pancreatic Acinar Cell CarcinomaTerminatedNCT05286827Phase 2Results posted
• Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian CancerActive, not recruitingNCT05276973Phase 1Results posted
• A Clinical Trial to Evaluate the Safety and Immunogenicity of BG505 MD39.3, BG505 MD39.3 gp151, and BG505 MD39.3 gp151 CD4KO HIV Trimer mRNA Vaccines in Healthy, HIV-uninfected Adult ParticipantsActive, not recruitingNCT05217641Phase 1Results posted
• Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (VIPOR) for Diffuse Large B-cell Lymphoma Involving the Central Nervous SystemActive, not recruitingNCT05211336Phase 1Results posted
• Testing an Omega-3 Fatty Acid-Based Anti-Cancer Therapy for Patients With Triple-Negative Inflammatory Breast Cancer That Has Spread to Other Parts of the BodyTerminatedNCT05198843Phase 1/2Results posted
• Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal CarcinomatosisCompletedNCT05185947Phase 2Results posted
• A Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of PGDM1400LS Alone and in Combination With VRC07-523LS and PGT121.414.LS in Healthy, HIV-uninfected Adult ParticipantsCompletedNCT05184452Phase 1Results posted
• Targeted Investigation of Microbiome EliminationTerminatedNCT05177328Phase 1Results posted
• Non-invasive Intermittent Theta Burst Stimulation of the Dorsolateral Prefrontal Cortex in Functional Movement DisordersActive, not recruitingNCT05155059Not applicableResults posted
• BMS-986253 in Myelodysplastic SyndromesTerminatedNCT05148234Phase 1/2Results posted
• Highest Dose of Uproleselan in Combination With Fludarabine and Cytarabine for Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Mixed Phenotype Acute Leukemia Relapsed or Refractory That Expresses E-selectin Ligand on the Cell MembraneActive, not recruitingNCT05146739Phase 1Results posted
• Testing the Combination of Anti-Cancer Drugs Talazoparib and Temozolomide in Patients With Advanced Stage Rare Cancers, RARE 2 TrialActive, not recruitingNCT05142241Phase 2Results posted
• Study of the Transmission-Blocking Vaccine Pfs230D1-EPA/Matrix-M Against Malaria in Adults in MaliCompletedNCT05135273Phase 1Results posted
• Evaluation of Two Zika Viruses for Use in Controlled Human Infection Models (CHIM)CompletedNCT05123222Phase 1Results posted
• Trial to Evaluate the Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA)-Based Anti-Cytomegalovirus (CMV) Vaccine (Triplex®)CompletedNCT05099965Phase 2Results posted
• Human Laboratory Study of ASP8062 for Alcohol Use DisorderCompletedNCT05096117Phase 2Results posted
• Blood-Stage Plasmodium Vivax Cell BankCompletedNCT05095272Phase 1Results posted
• Identifying Decision Making Parameters in Healthy Volunteers and Anxiety PatientsCompletedNCT05092971Not applicableResults posted
• COVID Protection After Transplant-Immunosuppression ReductionCompletedNCT05077254Phase 2Results posted
• Elimusertib for the Treatment of Relapsed or Refractory Solid TumorsActive, not recruitingNCT05071209Phase 1/2Results posted
• PET Imaging of Cyclooxygenase in Multiple SclerosisTerminatedNCT05062083Phase 2Results posted
• An Evaluation of Repeated Oral Doses of JNJ-64281802 Against DENV-3 ChallengeCompletedNCT05048875Phase 2Results posted
• Evaluation of Tofacitinib in Prevention of Photosensitivity in LupusCompletedNCT05048238Phase 1Results posted
• T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial CancersTerminatedNCT05035407Phase 1Results posted
• Characterization of Tissue-Specific Immune Responses to Bronchoscopic Instillation of Mycobacterial Antigens Into the Human LungCompletedNCT05027958Early Phase 1Results posted
• Safety and Immunogenicity of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza VaccineCompletedNCT05027932Phase 1Results posted
• Trial to Evaluate L9LS in Healthy AdultsCompletedNCT05019729Phase 1Results posted
• Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON).CompletedNCT05012098Phase 2Results posted
• 18F-DCFPyL PET/CT in Hepatocellular CarcinomaTerminatedNCT05009979Phase 2Results posted
• Linezolid Dosing Strategies in Drug-Resistant TBCompletedNCT05007821Phase 2Results posted
• COVID-19 Booster Vaccine in Autoimmune Disease Non-RespondersTerminatedNCT05000216Phase 2Results posted
• ACTIV-5 / Big Effect Trial (BET-C) for the Treatment of COVID-19CompletedNCT04988035Phase 2Results posted
• Influenza Challenge Study to Determine the Optimal Infection Dose and Safety of a Recombinant H3N2 (A/Texas/71/2017 (H3N2, Clade 3C3a) Influenza StrainCompletedNCT04978454Phase 1Results posted
• The Safety of Administering a Second Dose of a COVID-19 mRNA Vaccine in Individuals Who Experienced a Systemic Allergic Reaction to an Initial DoseCompletedNCT04977479Phase 2Results posted
• Optic-to-Audio Device in a Pediatric Cohort With CLN3-related Conditions or Low VisionTerminatedNCT04974307Not applicableResults posted
• COVID-19 Protection After Transplant Pilot StudyCompletedNCT04969263Phase 2Results posted
• Vaccination for Recovered Inpatients With COVID-19 (VATICO)CompletedNCT04969250Phase 4Results posted
• Assess the Safety and Immunogenicity of One or Two Doses of Sing2016 M2SR H3N2 Influenza VaccineTerminatedNCT04960397Phase 1Results posted
• SARS-CoV-2 Immune Responses After COVID-19 Therapy and Subsequent VaccineCompletedNCT04952402Phase 4Results posted
• Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract CancerActive, not recruitingNCT04941287Phase 2Results posted
• Immunotherapy With or Without Radiation Therapy for Metastatic Urothelial CancerTerminatedNCT04936230Phase 2Results posted
• Copanlisib With Dose-Adjusted EPOCH-R in Relapsed and Refractory Burkitt Lymphoma and Other High-Grade B-cell LymphomasTerminatedNCT04933617Phase 1Results posted
• Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD)TerminatedNCT04918147Phase 2Results posted
• Evaluating the Safety and Immunogenicity of Stabilized CH505 TF chTrimer in Healthy, HIV-uninfected Adult Participants.CompletedNCT04915768Phase 1Results posted
• First-in-Human Clinical Trial of a Mosaic Quadrivalent Influenza Vaccine Compared With a Licensed Inactivated Seasonal QIV in Healthy AdultsCompletedNCT04896086Phase 1Results posted
• Superenhancer Inhibitor Minnelide in Advanced Refractory Adenosquamous Carcinoma of the Pancreas (ASCP)CompletedNCT04896073Phase 2Results posted
• Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) After Receipt of EUA VaccinesCompletedNCT04889209Phase 1/2Results posted
• Liraglutide (Saxenda(R)) in Adolescents With Obesity After Sleeve GastrectomyCompletedNCT04883346Phase 2Results posted
• Experimental Human Infection With Neisseria Gonorrhoeae (LptA Trial)CompletedNCT04870138Phase 1Results posted
• Managing Cancer and Living Meaningfully (CALM) Therapy in Individuals Diagnosed With a Primary Brain TumorCompletedNCT04852302Not applicableResults posted
• COVID-19 Vaccination and Outcomes in Individuals With and Without Immune Deficiencies and DysregulationsCompletedNCT04852276Results posted
• A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor TherapyCompletedNCT04847050Phase 2Results posted
• ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19CompletedNCT04843761Phase 3Results posted
• Intratumor Injection of Anti-Mesothelin Immunotoxin LMB-100 With Ipilimumab in Malignant MesotheliomaTerminatedNCT04840615Phase 1Results posted
• A Study to Evaluate the Anti-inflammatory Effects of Letermovir (Prevymis) in Adults With Human Immunodeficiency Virus (HIV)-1 and Asymptomatic Cytomegalovirus (CMV) Who Are on Suppressive Antiretroviral Therapy, Plus Its Effect on Chronic Inflammation, HIV Persistence and Other Clinical Outcomes.TerminatedNCT04840199Phase 2Results posted
• A Study to Assess the Safety and Immune Response to Env-C DNA and Protein Vaccines in KenyaCompletedNCT04826094Phase 1Results posted
• Safety, Tolerability and Acceptability of Long-Acting Cabotegravir (CAB LA) for the Prevention of HIV Among Adolescent FemalesCompletedNCT04824131Phase 2Results posted
• Antidepressant Effects of TS-161 in Treatment-Resistant DepressionTerminatedNCT04821271Phase 2Results posted
• Testing Oral Decitabine and Cedazuridine (ASTX727) in Combination With Venetoclax for Higher-Risk Acute Myeloid Leukemia PatientsActive, not recruitingNCT04817241Phase 1/2Results posted
• A Study of SARS CoV-2 Infection and Potential Transmission in Individuals Immunized With Moderna COVID-19 VaccineCompletedNCT04811664Phase 3Results posted
• Comparing the Addition of an Anti-Cancer Drug, Pomalidomide, to the Usual Chemotherapy Treatment (Daunorubicin and Cytarabine Liposome) in Newly Diagnosed Acute Myeloid Leukemia With Myelodysplastic Syndrome-Related ChangesActive, not recruitingNCT04802161Phase 2Results posted
• Vitamin E Dosing StudyCompletedNCT04801849Phase 2Results posted
• Safety and Immunogenicity Study of a SARS-CoV-2 (COVID-19) Variant Vaccine (mRNA-1273.351) in Naïve and Previously Vaccinated AdultsCompletedNCT04785144Phase 1Results posted
• Chimpanzee Adenovirus and Self-Amplifying mRNA Prime-Boost Prophylactic Vaccines Against SARS-CoV-2 in Healthy AdultsCompletedNCT04776317Phase 1Results posted
• DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus BacteremiaCompletedNCT04775953Phase 2Results posted
• COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 VaccinationsCompletedNCT04761822Phase 2Results posted
• Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed OsteosarcomaTerminatedNCT04751383Phase 1Results posted
• Tolebrutinib, a Brain-penetrant Bruton's Tyrosine Kinase Inhibitor, for the Modulation of Chronically Inflamed White Matter Lesions in Multiple SclerosisActive, not recruitingNCT04742400Phase 2Results posted

← National Institutes of Health overview and focus areas